Pier Vincenzo Piazza
Overview
Explore the profile of Pier Vincenzo Piazza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
3044
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grasso M, Fidilio A, LEpiscopo F, Recupero M, Barone C, Bacalini M, et al.
Front Pharmacol
. 2024 Apr;
15:1379965.
PMID: 38576478
Almost all individuals with Down's syndrome (DS) show the characteristic neuropathological features of Alzheimer's disease (AD) by the age of 40, yet not every individual with DS experiences symptoms of...
2.
Haney M, Vallee M, Fabre S, Collins Reed S, Zanese M, Campistron G, et al.
Nat Med
. 2023 Jun;
29(6):1487-1499.
PMID: 37291212
Cannabis use disorder (CUD) is widespread, and there is no pharmacotherapy to facilitate its treatment. AEF0117, the first of a new pharmacological class, is a signaling-specific inhibitor of the cannabinoid...
3.
Kearney-Ramos T, Herrmann E, Belluomo I, Matias I, Vallee M, Monlezun S, et al.
Cannabis Cannabinoid Res
. 2022 Apr;
8(6):1069-1078.
PMID: 35486827
The endogenous cannabinoid system (ECS), including the endocannabinoids (eCBs), anandamide (AEA), and 2-arachidonoylglycerol (2-AG), plays an integral role in psychophysiological functions. Although frequent cannabis use is associated with adaptations in...
4.
Di Franco N, Drutel G, Roullot-Lacarriere V, Julio-Kalajzic F, Lalanne V, Grel A, et al.
Mol Cell Neurosci
. 2022 Feb;
119:103705.
PMID: 35158060
Down syndrome (DS) or Trisomy 21 is the most common genetic cause of mental retardation with severe learning and memory deficits. DS is due to the complete or partial triplication...
5.
Aloisi E, Le Corf K, Dupuis J, Zhang P, Ginger M, Labrousse V, et al.
Nat Commun
. 2017 Oct;
8(1):1103.
PMID: 29062097
Metabotropic glutamate receptor subtype 5 (mGluR5) is crucially implicated in the pathophysiology of Fragile X Syndrome (FXS); however, its dysfunction at the sub-cellular level, and related synaptic and cognitive phenotypes...
6.
Houede N, Piazza P, Pourquier P
Front Biosci (Landmark Ed)
. 2017 Sep;
23(7):1292-1309.
PMID: 28930600
Prostate cancer is the third leading cause of death by cancer in men. Surgery or hormone deprivation usually contains the progression of the local forms of the disease. In metastatic...
7.
Piomelli D, Haney M, Budney A, Piazza P
Cannabis Cannabinoid Res
. 2017 Sep;
1(1):47-53.
PMID: 28861480
No abstract available.
8.
Devroye C, Cathala A, Piazza P, Spampinato U
Pharmacol Ther
. 2017 Aug;
181:143-155.
PMID: 28757154
The serotonin receptor (5-HTR), which was first cloned and characterized in the rat stomach fundus, is the most recent addition to the 5-HTR family. While its involvement in the regulation...
9.
Caraci F, Enna S, Zohar J, Racagni G, Zalsman G, van den Brink W, et al.
Br J Clin Pharmacol
. 2017 Apr;
83(8):1614-1616.
PMID: 28401576
The Neuroscience-based Nomenclature (NbN) for psychotropic drugs was developed as an alternative to the current Anatomical Therapeutic Chemical (ATC) indication-based classification in order to provide more precise designations for this...
10.
Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza P, et al.
Neuropharmacology
. 2017 Apr;
119:91-99.
PMID: 28390892
Recent studies have shown that serotonin receptor (5-HTR) antagonists exert opposite facilitatory and inhibitory effects on dopamine (DA) release in the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAc),...